On the public citation graph
Therapeutic strategies for inhibiting invasion in glioblastoma
Inferred edges come from two machine sources: sweeps of open repository
metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is
labelled with the one it came from. Neither is a complete citation index — absence here is not
evidence of absence.
1 of the 169 references listed on this page is in the Retraction Watch database as retracted (export 2026-11-18): 10.1038/sj.onc.1207616 (notice 2025-04-29).
Dataset join, best-effort; this page does not check the publisher record.
Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0);
dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated
CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/ijc.21534openalex-snapshotInhibition of proteasome activity, nuclear factor-KB translocation and cell survival by the antialcoholism drug disulfiram
inferredcites →https://doi.org/10.1002/jcb.21400openalex-snapshotLRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP‐2 activation by reducing SDF‐1α/CXCR4‐mediated ERK1/2 and Akt signaling pathways
inferredcites →https://doi.org/10.1007/s10014-005-0186-1openalex-snapshotExpression of the constitutively activated RelA/NF-κB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion
inferredcites →https://doi.org/10.1007/s11060-005-9098-5openalex-snapshotRandomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation★
inferredcites →https://doi.org/10.1007/s11060-006-9160-yopenalex-snapshotPhase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: A relationship among efficacy, joint toxicity and anticonvulsant status
inferredcites →https://doi.org/10.1016/j.ccr.2006.11.023openalex-snapshotHigh TGFβ-Smad Activity Confers Poor Prognosis in Glioma Patients and Promotes Cell Proliferation Depending on the Methylation of the PDGF-B Gene
inferredcites →https://doi.org/10.1016/s0002-9440(10)62308-5openalex-snapshotUp-Regulation of Angiopoietin-2, Matrix Metalloprotease-2, Membrane Type 1 Metalloprotease, and Laminin 5 γ 2 Correlates with the Invasiveness of Human Glioma
inferredcites →https://doi.org/10.1016/s0002-9440(10)63429-3openalex-snapshotADAM12 Is Selectively Overexpressed in Human Glioblastomas and Is Associated with Glioblastoma Cell Proliferation and Shedding of Heparin-Binding Epidermal Growth Factor
inferredcites →https://doi.org/10.1017/s1740925x04000237openalex-snapshotDownregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth
inferredcites →https://doi.org/10.1038/sj.onc.1207616openalex-snapshotRETRACTED ARTICLE: Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis
inferredcites →https://doi.org/10.1038/sj.onc.1208169openalex-snapshotNonsteroidal anti-inflammatory agents differ in their ability to suppress NF-κB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation
inferredcites →https://doi.org/10.1073/pnas.2332186100openalex-snapshotIIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion
inferredcites →https://doi.org/10.1074/jbc.m007204200openalex-snapshotInhibition of NF-κB Activation by Arsenite through Reaction with a Critical Cysteine in the Activation Loop of IκB Kinase
inferredcites →https://doi.org/10.1074/jbc.m409906200openalex-snapshotThe Tumor Necrosis Factor-like Weak Inducer of Apoptosis (TWEAK)-Fibroblast Growth Factor-inducible 14 (Fn14) Signaling System Regulates Glioma Cell Survival via NFκB Pathway Activation and BCL-XL/BCL-W Expression
inferredcites →https://doi.org/10.1124/mol.106.033167openalex-snapshotEvidence That Curcumin Suppresses the Growth of Malignant Gliomas in Vitro and in Vivo through Induction of Autophagy: Role of Akt and Extracellular Signal-Regulated Kinase Signaling Pathways
inferredcites →https://doi.org/10.1158/0008-5472.can-04-1013openalex-snapshotSD-208, a Novel Transforming Growth Factor β Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma CellsIn vitroandIn vivo
inferredcites →https://doi.org/10.1158/0008-5472.can-05-1042openalex-snapshotPerifosine Inhibits Multiple Signaling Pathways in Glial Progenitors and Cooperates With Temozolomide to Arrest Cell Proliferation in Gliomas In vivo
inferredcites →https://doi.org/10.1158/0008-5472.can-05-3329openalex-snapshotFully Human Monoclonal Antibodies to Hepatocyte Growth Factor with Therapeutic Potential against Hepatocyte Growth Factor/c-Met–Dependent Human Tumors
inferredcites →https://doi.org/10.1158/1078-0432.ccr-04-2270openalex-snapshotInhibition of Glioblastoma Angiogenesis and Invasion by Combined Treatments Directed Against Vascular Endothelial Growth Factor Receptor-2, Epidermal Growth Factor Receptor, and Vascular Endothelial-Cadherin
inferredcites →https://doi.org/10.1158/1078-0432.ccr-08-0147openalex-snapshotInhibition of Glioblastoma Growth in a Highly Invasive Nude Mouse Model Can Be Achieved by Targeting Epidermal Growth Factor Receptor but not Vascular Endothelial Growth Factor Receptor-2
inferredcites →https://doi.org/10.1158/1535-7163.737.3.6openalex-snapshotSB-431542, a small molecule transforming growth factor-β-receptor antagonist, inhibits human glioma cell line proliferation and motility
inferredcites →https://doi.org/10.1158/1535-7163.mct-08-0017openalex-snapshotIdentification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
inferredcites →https://doi.org/10.1172/jci115516openalex-snapshotGlioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells.
inferredcites →https://doi.org/10.1186/1471-2407-6-29openalex-snapshotA phase 1–2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668]
inferredcites →https://doi.org/10.1200/jco.20.5.1383openalex-snapshotPhase II Trial of Temozolomide Plus the Matrix Metalloproteinase Inhibitor, Marimastat, in Recurrent and Progressive Glioblastoma Multiforme
inferredcites →https://doi.org/10.1200/jco.2005.03.089openalex-snapshotPossible Future Issues in the Treatment of Glioblastomas: Special Emphasis on Cell Migration and the Resistance of Migrating Glioblastoma Cells to Apoptosis
inferredcites →https://doi.org/10.1200/jco.2005.03.4082openalex-snapshotSalvage Radioimmunotherapy With Murine Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 for Patients With Recurrent Primary and Metastatic Malignant Brain Tumors: Phase II Study Results
inferredcites →https://doi.org/10.1200/jco.2008.16.7510openalex-snapshotRandomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme
inferredcites →https://doi.org/10.1200/jco.2008.16.9235openalex-snapshotPhase II Study of Imatinib in Patients With Recurrent Gliomas of Various Histologies: A European Organisation for Research and Treatment of Cancer Brain Tumor Group Study
inferredcites →https://doi.org/10.1200/jco.2008.26.15_suppl.2010bopenalex-snapshotA phase II, randomized, non-comparative clinical trial of the effect of bevacizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival (PFS6) in recurrent, treatment-refractory glioblastoma (GBM)
inferredcites →https://doi.org/10.1517/14728220802560307openalex-snapshotThe role of matrix metalloproteinases in the pathophysiology and progression of human nervous system malignancies: a chance for the development of targeted therapeutic approaches?
inferredcites →https://doi.org/10.3892/ijo.29.1.73openalex-snapshotPTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/jnr.22794openalex-snapshotCalpain 2 is required for the invasion of glioblastoma cells in the zebrafish brain microenvironment
inferred← citeshttps://doi.org/10.1002/jnr.23140openalex-snapshotDifferential effects of low‐ and high‐dose GW2974, a dual epidermal growth factor receptor and HER2 kinase inhibitor, on glioblastoma multiforme invasion
inferred← citeshttps://doi.org/10.1002/jnr.24776openalex-snapshotUnderstanding the glioblastoma tumor biology to optimize photodynamic therapy: From molecular to cellular events
inferred← citeshttps://doi.org/10.1016/j.jphs.2017.04.003openalex-snapshotPlumbagin suppresses the migration and invasion of glioma cells via downregulation of MMP-2/9 expression and inaction of PI3K/Akt signaling pathway in vitro
inferred← citeshttps://doi.org/10.1038/onc.2014.75openalex-snapshotOncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2
inferred← citeshttps://doi.org/10.1038/s41598-021-95753-6openalex-snapshotGlioblastoma invasion factor ODZ1 is induced by microenvironmental signals through activation of a Stat3-dependent transcriptional pathway
inferred← citeshttps://doi.org/10.1039/c4md00264dopenalex-snapshotDiscovery of mitochondria-targeting berberine derivatives as the inhibitors of proliferation, invasion and migration against rat C6 and human U87 glioma cells
inferred← citeshttps://doi.org/10.1042/bsr20180738openalex-snapshotCasticin inhibits breast cancer cell migration and invasion by down-regulation of PI3K/Akt signaling pathway
inferred← citeshttps://doi.org/10.1093/neuonc/nos263openalex-snapshotMolecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group
inferred← citeshttps://doi.org/10.1111/bph.17464openalex-snapshot7 I, a structurally modified sinomenine, exerts dual anti‐GBM effects by inhibiting glioblastoma proliferation and inducing necroptosis which further mediates lysosomal cell death
inferred← citeshttps://doi.org/10.1111/cns.12606openalex-snapshotOverexpression of Paxillin Correlates with Tumor Progression and Predicts Poor Survival in Glioblastoma
inferred← citeshttps://doi.org/10.1111/jnc.12831openalex-snapshotGirdin, an actin‐binding protein, is critical for migration, adhesion, and invasion of human glioblastoma cells
inferred← citeshttps://doi.org/10.1117/12.2225234openalex-snapshotDetection limits of 405 nm and 633 nm excited PpIX fluorescence for brain tumor detection during stereotactic biopsy
inferred← citeshttps://doi.org/10.1371/journal.pone.0062852openalex-snapshotTumor Derived Mutations of Protein Tyrosine Phosphatase Receptor Type K Affect Its Function and Alter Sensitivity to Chemotherapeutics in Glioma
inferred← citeshttps://doi.org/10.1371/journal.pone.0151815openalex-snapshotComparative Analysis of Matrix Metalloproteinase Family Members Reveals That MMP9 Predicts Survival and Response to Temozolomide in Patients with Primary Glioblastoma
inferred← citeshttps://doi.org/10.1586/ern.12.84openalex-snapshotRole for cytotoxic chemotherapy in patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series
inferred← citeshttps://doi.org/10.17077/etd.ua1x1jgyopenalex-snapshotProtein Tyrosine Phosphatase Receptor Type Kappa Is A Glioma Tumor Suppressor That Predicts Survival And Response To Therapy
inferred← citeshttps://doi.org/10.18632/oncotarget.18026openalex-snapshotEndoplasmic reticulum chaperone prolyl 4-hydroxylase, beta polypeptide (P4HB) promotes malignant phenotypes in glioma via MAPK signaling
inferred← citeshttps://doi.org/10.2741/e217openalex-snapshotSingle nucleotide polymorphisms in IL-4Ra IL-13 and STAT6 genes occurs in brain glioma
inferred← citeshttps://doi.org/10.3390/cells13090766openalex-snapshotThe Invasion Factor ODZ1 Is Upregulated through an Epidermal Growth Factor Receptor-Induced Pathway in Primary Glioblastoma Cells
inferred← citeshttps://doi.org/10.3390/jcm11195855openalex-snapshotTumor Treating Fields Combine with Temozolomide for Newly Diagnosed Glioblastoma: A Retrospective Analysis of Chinese Patients in a Single Center
inferred← citeshttps://doi.org/10.5282/edoc.17115openalex-snapshotFluorescence spectroscopic measurements of absolute and relative photosensitizer concentrations in tissue for the optimization of photodynamic therapy
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID:
icsacinstitute.org/submit.